(Self-paced, Virtual) Cybersecurity & Digital Health Training for Health Science Professionals
Cybersecurity & Digital Health Training (Self-paced, Virtual)
OBIO® is proud to deliver the Cybersecurity & Digital Health Training for Health Science Professionals. The program focuses on the critical intersection of software development and cybersecurity, particularly in the context of health products and medical devices. It will cover regulatory aspects as outlined in Health Canada’s guidance for software as a medical device, addressing data compliance, and secure data management throughout the Software Development Life Cycle (SDLC).
The Cybersecurity & Digital Health Training is now offered year-round as a self-paced, fully virtual program
Masterclass: Defence Readiness & Go-to-Market Strategy for Healthcare Start-ups
*Thank you for your interest! Applications are now closed.*
Canada’s First Dual-Use Masterclass for Life Sciences & Health Tech Innovators
Supported in part by funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP).
The Current Landscape
The convergence of health technology and national security is a strategic imperative for Canada. In alignment with Canada’s Defence Industrial Strategy, which prioritizes strategic autonomy, secure domestic supply chains and sovereign control of Canadian intellectual property (IP), strengthening the national life sciences & health tech sector is critical to human resilience, biodefence and security.
Canada’s life sciences sector, including small and medium-sized enterprises (SMEs) developing world-class innovations, is already demonstrating extraordinary global leadership: four of the five Canadian companies selected for recent NATO DIANA Human Resilience and Biotechnologies cohorts have been supported by OBIO®. Furthermore, 60% of OBIO-supported companies are actively exploring dual-use applications for their technologies.
Program Overview
While foreign defence agencies actively fund Canadian SMEs, without strategic alignment, these investments risk shifting domestically-supported IP and economic returns away from Canada. To bridge the gap between civilian healthcare innovation and military applications and ensure the protection of our country’s sovereign innovation capabilities, OBIO® is proudly launching Canada’s first comprehensive Masterclass program.
Introducing the 2026 cohort
This program is designed to:
Prepare life sciences & health tech SMEs to commercialize dual-use applications for their technologies, and provide them with a customized Defence Go-to-Market Plan tailored to defence readiness frameworks
Equip executive leaders with the knowledge and strategic insights they need to navigate the defence market
Enable companies to access non-dilutive funding
Foster domestic procurement readiness
Align commercial health innovations with Canada’s defence priorities and NATO standards
Cohort Details:
Dates & Times:
Four virtual sessions: October 8 & 22 (9:30am-12pm ET) / November 5 (9:30am-1pm ET) & November 19 (9:30am-2pm ET)
One in-person tactical workshop: December 3 – All day
Cohort size:
Strictly limited to ten participants for the inaugural cohort to ensure high-impact, personalized advisory and deep participant engagement.
Participation fee:
$200 CAD for selected participants
Eligibility
SMEs supported by NRC IRAP in the life sciences & health tech sector (therapeutics, medtech, diagnostics and digital health) with dual-use ambitions or scaling readiness are eligible to apply for the Masterclass.
Extend Your Runway: Map & Secure Non-Dilutive Funding in Health & Life Sciences
Webinar
Join us on November 5 for a practical session led by OBIO® member PeakR&D on using SR&ED, grants and other non-dilutive funding to support R&D, validation, and commercialization in Canada.
Extend your runway and reach your next milestone with less equity dilution by treating non-dilutive capital as a strategic, multi-year component of your funding strategy, rather than a series of one-off applications.
The session will cover:
What non-dilutive funding is available for life sciences and health tech companies at different stages
How to identify the right programs and combine SR&ED, grants, and other funding opportunities
What funders and SR&ED reviewers look for, and common mistakes that can lead to delays, reductions or rejections
Who should attend:
Canadian life sciences and health tech companies across different stages of development, from early R&D and validation through regulatory milestones, commercialization, and scale-up.
Founders and CEOs setting growth and funding strategy
CFOs and finance leaders managing R&D budgets, tax credits, and cash planning
R&D, scientific and innovation leaders planning R&D projects and milestones
The meeting invite and details will be included in the registrants' confirmation email.
Navigating RAII 2.0: Southern Ontario AI Funding Guide
Artificial intelligence is changing how businesses operate, innovate and compete. Through the Regional Artificial Intelligence Initiative, the Government of Canada is helping businesses and organizations in southern Ontario use AI responsibly to improve productivity, strengthen competitiveness and grow.
Join us for an exclusive, deep-dive virtual session on October 29 (1 - 2 pm ET) on the expanded Regional Artificial Intelligence Initiative (RAII) delivered by the Federal Economic Development Agency for Southern Ontario (FedDev Ontario). With an additional $500 million in federal funding over five years under Canada's National AI Strategy, there is no better time to accelerate your organization's AI ambitions.
The program provides funding to:
Help businesses and organizations adopt and integrate AI to improve productivity, competitiveness and resilience
Help Canadian AI companies bring their products and services to market and scale in Canada and globally
Strengthen the organizations and networks that help businesses adopt and commercialize AI
We invite you to join “Navigating RAII 2.0: Southern Ontario AI Funding Guide”, a virtual information session led by FedDev Ontario.
Who should attend?
This session is intended for businesses in:
Established life sciences, health technology or energy & natural resources businesses and organizations looking to integrate AI
Innovators scaling a new AI product
Non-profit ecosystem organizations supporting AI adoption, commercialization, and scale-up
Participants will learn about:
The three RAII 2.0 program streams;
Eligibility requirements and program parameters;
The application process and intake timelines; and
How interested businesses and organizations can connect with FedDev Ontario for follow-up discussions and support.
Life Sciences Central 1-Year Anniversary
*This event is full. Thank you for your interest.*
Join us as we celebrate the first anniversary of Life Sciences Central!
One year ago, Life Sciences Central launched with a bold vision: to make Ontario’s world-class life sciences ecosystem easier to navigate and accelerate the path from innovation to commercialization. Today, that vision is becoming reality. Through a connected network model, a single intake process, coordinated support and structured programming, Life Sciences Central is helping founders access the resources they need to grow.
More than 130 companies across therapeutics, medtech, diagnostics, digital health, and consumer health have already joined the network. Celebrate this milestone with us and discover what’s next for strengthening Ontario’s innovation pipeline and scaling the next generation of life sciences leaders.
Panel Discussion
The event will feature a panel discussion on Rethinking Capital: How Early-Stage Health Companies Can Access Funding in a New Era.
The process of raising capital has never been more challenging, or more fragmented. Early-stage biotech and medtech companies increasingly receive support from investors who bring more than money: networks, validation, clinical expertise, strategic partnerships and long-term support.
This panel will explore:
How new funding models help founders bridge the gap from discovery to commercialization
How entrepreneurs can identify the right capital partners for each stage of growth.
Meet the Panelists
Venture Showcase
Agenda
9:00 - 9:30 am
Registration & Networking
9:30 - 9:45 am
Opening Remarks
9:45 - 10:15 am
Venture Showcase
10:15 - 11:00 am
Panel Discussion: Rethinking Capital: How Early-Stage
Health Companies Can Access Funding in a New Era
11:00 am - 12:00 pm
Closing Remarks and Networking
*This event is full. Thank you for your interest.*
OBIO® WiHI Breakfast: Financing and Growth Pathways for Health & Life Sciences Companies
Financing and Growth Pathways for Health & Life Sciences Companies
Join us on October 16 for a conversation with Stephany Sani-Edwards and Lamisa Ataei from BDC to explore the different ways BDC supports health and life sciences companies as they grow and scale.
The session will provide an overview of BDC’s support across debt financing, venture investment, advisory services and other resources, with a focus on opportunities for women founders and women-led companies. Guest speakers will also share insights on BDC’s life sciences venture activities and highlight how companies can engage with BDC at different stages of growth.
We look forward to seeing you there!
*This is an invitation-only event.
Target Product Profiles: From Bench to Bedside
*This session has been cancelled but will be rescheduled at a later time.
Please stay tuned for more details.*
Join us on October 14 for an interactive discussion on how early TPP decisions can help set your program up for a clearer path from bench to bedside.
For early-stage biotech companies, a Target Product Profile (TPP) is a powerful tool for shaping development strategy, communicating the value of a program, and aligning stakeholders around what success looks like.
This session will explore:
How TPPs should evolve as a program moves from early discovery toward clinical development
What founders and development teams should be thinking about early on
How to build a TPP, identify the key assumptions and evidence that will matter later, and anticipate potential development pitfalls before they become costly to address
Due to the limited space of the venue, all registered attendees must be approved and priority goes to Biotechnology companies participating in our competitive accelerator programs.
This is an in-person event only.
*This session has been cancelled but will be rescheduled at a later time.
Please stay tuned for more details.*
CDD x OBIO® Pub Night
Happy Hour
You’re invited to attend a fun night of networking hosted by CDD and OBIO®!
Join us for a relaxing, after-hours gathering bringing together biotech experts and members of the life sciences community. Come catch up with your peers or make some new connections!
When: October 8, 2026 at 5 - 8 pm
Where: Rooftop on College, 20 College Street, Toronto, Ontario M5G 1K2
What: A fun evening with some drinks & bites
We hope you can make it and look forward to celebrating with you!
*This event is full. Thank you for your interest.*
OBIO’s Annual Public Meeting & Reception
*This event is full! Thank you for your interest.*
You're invited to the most exciting matchmaking in the life sciences and health tech community!
Join us for OBIO’s Annual Public Meeting & Reception on Thursday, September 17, from 5 - 8 pm, in downtown Toronto.
Inspired by the iconic Dating Game TV show, this year's event brings an investment twist that could lead to the next great partnership!
As always, we will also reflect on our achievements in 2026 and thank our board of directors, members and ecosystem partners for their continued support and commitment to advancing innovation in our vibrant sector.
- SPECIAL HIGHLIGHTS -
Pitching Competition
Watch OBIO-supported companies deploy their pitching charm to an investor.
Networking Reception
Enjoy drinks & hors d’oeuvres, while catching up with friends, partners and the wider ecosystem, and celebrating the spirit of life sciences innovation.
❤️Will there be a match? Your vote will decide!
*This event is full! Thank you for your interest.*
Not an OBIO® member yet? Become one today!
OBIO® WiHI Breakfast: Beyond Borders: Global Growth Pathways for Women-Led Health & Life Sciences Companies
Beyond Borders: Global Growth Pathways for Women-Led Health & Life Sciences Companies
Expanding into international markets requires more than a strong product: it requires the right market insights, partnerships, regulatory strategy, and timing.
Join us on September 9 for our next OBIO® Women in Health Initiative (WiHI) breakfast, featuring Trade Commissioners Aude Alexia Véronneau and Zinnia Jamshed Qureshi, for a practical conversation on how women-led health and life sciences companies can explore global opportunities and build an effective pathway to export their technologies.
With perspectives spanning life sciences, digital health, women’s health, and international business development, the session will offer actionable guidance for companies considering their first—or next—market beyond Canada.
We look forward to seeing you there!
*This is an invitation-only event.
Biotech VC Valuation: How the Other Side of the Table Thinks About Valuation
Join us for a workshop on August 26, hosted by Life Sciences Central [powered by MaRS, OBIO® and TIAP] on biotech VC valuation.
Raising venture capital is about much more than negotiating a valuation. In early-stage biotech, valuation reflects scientific risk, development milestones, financing strategy, ownership, and the potential to create future value.
Led by Xin Hang (Senior Principal at CTI Life Sciences Fund and MaRS' Advisor), this workshop is designed primarily for first-time biotech founders and CEOs preparing to raise institutional capital.
What to expect from the session:
Practical, VC-focused framework for understanding how biotech companies are valued and financed.
How venture investors evaluate opportunities, assess risk, determine ownership targets, estimate valuation, and review financing terms.
Forecasting, common valuation methodologies, term sheet economics, and fundraising strategy—giving founders a better understanding of what drives investment decisions.
This event is free, but registration is subject to approval.
ENGAGE Entrepreneurship Learning Pathway
Join BioHubNet ENGAGE Entrepreneurship Learning Pathway, featuring 3.5-days of accelerated entrepreneuship training by OBIO®, with personalized support to build the skills and knowledge you need to grow your venture. This bootcamp is designed for graduate students/postdoctoral fellows/research associates/techs leading life sciences ventures at the pre-seed stage, with at least an invention disclosure filed with their institution.
What you’ll master:
Pitch deck creation and confident investor presentations
Regulatory processes involved in product developement
Financing options and funding stages for growing ventures
Business plan development and startup strategy
Negotiation techniques for venture building and partnerships
Intellectual property protection and innovation factory
*Seats are limited and will be offered on a first come, first served basis*
Health Science Industry Training Course
Stem Cell Network is pleased to partner with OBIO® to offer the Health Science Industry Training Course. This 27-hour virtual course will empower up to 25 participants with the skills and knowledge to commercialize a therapeutic product or work in the health science industry.
Program highlights include:
Comprehensive training to build a foundation in the health science industry for biotechnology commercialization
Interactive modules led by industry experts, including case studies and workshops
Weekly virtual sessions over 9 weeks
Training modules include:
Innovation and commercialization
IP and licencing
Strategic business development
Project managementfor health science industry
Market intelligence
QMS/GMP& biomanufacturing
Finance, partnerships and contracts
Professional skills and business communications
Careers in the industry
*Applications are now closed*
Dual Use & Defence: Ontario’s Life Sciences & Clinical Trials Superpower
*This event is sold out. Thank you for your interest.*
Breakfast event at the 2026 BIO International Convention in San Diego
Clinical Trials Ontario and Life Sciences Central [powered by MaRS, OBIO® and TIAP] are bringing together leaders from across the sector for an event featuring a panel discussion on how Ontario and Canada’s life sciences and clinical trials ecosystem can support the advancement of dual-use biotechnology.
Join the event on Monday, June 22, 2026, at the Omni San Diego Hotel at the Ballpark for an opportunity to connect with peers, exchange ideas, and engage with Ontario’s dynamic life sciences community on a global stage.
The conversation will explore real-world examples, opportunities, and the unique assets that position Ontario as a global hub for this emerging area—from world-class researchers, institutions and trial infrastructure to collaborative networks and advantages that enable innovation at scale.
Meet the Panelists
This event is supported by:
*This event is sold out. Thank you for your interest.*
bioRSVP App
Discover how bioRSVP can help you cut through the noise and make intelligent, high-value connections at biotech's most important weeks.
Get a closer look at how this app can help you navigate conference week!
Getting Products into the Market – Accelerating Adoption in Healthcare
Join us for a workshop on June 17 hosted by Life Sciences Central [powered by MaRS, OBIO® and TIAP] focused on bringing innovations to the healthcare market.
Canada’s health innovation landscape is rich with groundbreaking technologies, yet many companies still face a long and complex path to adoption within health systems. This workshop explores how innovators, healthcare organizations, and ecosystem leaders can accelerate the path to real‑world implementation, while navigating the unique procurement challenges that shape the Canadian market.
Bibaswan Ghoshal, Senior Director, Technology Adoption at OBIO®, will lead an engaging discussion on health technology adoption in Canada and share valuable insights from OBIO’s Early Adopter Health Network (EAHN®) on supporting partnerships between Canadian health technology companies and the healthcare system.
Agenda:
3:00 – 3:15 pm: Registration
3:15 – 4:15 pm: Presentation + Q&A
4:15 – 5:00 pm: Networking
This event is free for all participants. Spots are limited.
OBIO® WiHI Breakfast: Founders, Funders, and the Future of Cancer Care
Founders, Funders, and the Future of Cancer Care
Join us for our last Women Leader in Health breakfast session before the Summer break - an opportunity to learn about FACIT and Lumira’s Cancer Breakthrough Fund programs and investment thesis, and how these support the next generation of oncology ventures. This conversation, led by Connie Chen from FACIT and Suman Rao from Lumira Ventures, will bring together perspectives from across the health and life sciences community to discuss how new discoveries in oncology are being translated into real-world impact.
This session is ideal for anyone interested in healthcare, innovation, and the future of cancer treatment, from researchers and entrepreneurs to policymakers and community members.
We look forward to seeing you there!
*This is an invitation-only event.
Life Sciences Networking Night - Ottawa Innovation Week
*This event if full. Thank you for your interest.*
OBIO® and Capital BioVentures are pleased to invite you to their upcoming Networking Night in Ottawa on June 9.
Hosted with the support of Invest Ottawa, this evening mixer brings together the life sciences and heath tech community in Ottawa, including industry professionals, academic leaders, and innovators to build meaningful connections, exchange ideas, and spark future collaborations in the life sciences ecosystem.
We look forward to seeing you there!
Date:
Tuesday, June 9, 2026
Time:
5:00 - 7:00 PM EDT
Location:
The Foundry at the Bayview Yards
7 Bayview Station Rd, Ottawa, ON K1Y 2C5
Light snacks & drinks will be served.
*This event is free for all participants*
*This event if full. Thank you for your interest.*
OBIO® WiHI Breakfast: Accelerating Life Sciences: Navigating FedDev Ontario Funding & Support
Accelerating Life Sciences: Navigating FedDev Ontario Funding & Support
Whether you’re developing a new medical device, scaling a biotech venture, or navigating the path to clinical trials, securing the right capital is often the biggest hurdle. Join us for our next OBIO® Women in Health Initiative (WiHI) breakfast on May 8, featuring Fatouma Ahmed, Director of Special Projects at FedDev Ontario.
We will dive into the federal funding landscape, highlighting programs that provide the non-dilutive capital and strategic resources necessary to move from the lab to the global market.
Empower your innovation with the right federal support.
Space is limited—register today to secure your spot!
We look forward to seeing you there!
*This is an invitation-only event.
Fueling Innovation: Maximizing Business & Tax Incentives for Life Sciences & Health Tech Start-Ups
The journey from a Canadian lab to a global healthcare market is paved with both immense opportunity and complex regulatory hurdles. As we move through 2026, the "Canadian Advantage" has never been stronger for health tech and biotech firms that know how to leverage their corporate structure.
Join us in Toronto on May 5 for a workshop designed for founders and finance leaders to move beyond basic tax filing, helping you navigate the complexities of local and global incentives to extend your runway and accelerate your ROI.
We will explore:
How leveraging SR&ED and maintaining Canadian-Controlled Private Corporation (CCPC) status acts as a high-octane fuel for your R&D
How to protect that status while exploring international expansion and investment from foreign investors
Agenda
8:30 – 9 am:
Registration, networking, light breakfast
9 – 11:30 am:
Presentations & Discussion
Meet our Speakers
Event fee
OBIO® members: free
Non-members: $15 + tax
OBIO® WiHI Breakfast: Inside Osler's Deal Points Report 2026 and Life Sciences Investment Trends
OBIO® WiHI Breakfast
Join us for our next OBIO® Women in Health Initiative (WiHI) breakfast on April 24 for a conversation with legal and venture capital experts Jennifer Humphrey (Associate, Emerging and High Growth Companies at Osler, Hoskin & Harcourt LLP) and Evelyn Pau, PhD (Principal at Amplitude Ventures). Together, they will unpack the latest findings from Osler’s Deal Points Report on Venture Capital Financings, offering a deep dive into current deal trends, valuation benchmarks, and evolving financing terms. This session will provide valuable context on what these insights mean for life sciences founders and investors across Canada.
We look forward to seeing you there!
*This is an invitation-only event.
Navigating the 49th parallel: Cross-border structuring strategies for Canadian life sciences and healthtech companies
Navigating the 49th parallel: Cross-border structuring strategies for Canadian life sciences and healthtech companies
Are you building a Canadian life sciences or healthtech company with one eye firmly set on the U.S. market? The decisions you make today about your corporate structure and tax planning could define your company's trajectory for years to come. Join Torys and Life Sciences Central for an exclusive breakfast discussion, followed by networking. The panel discussion will share practical insights drawn from real transactions and help you ask the right questions when considering cross-border structuring.
This session will unpack the cross-border structuring and tax considerations that impact every venture-backed founder, such as:
How does raising U.S. capital affect CCPC status (and the valuable tax advantages that come with it);
Why do U.S. investors ask Canadian companies to move to the U.S. and what does that mean for how you structure your cap table; and
What is a Qualified Small Business Stock (QSBS).
Seats are limited. Breakfast will be served. Bring your appetite, and questions, and come ready for a frank conversation about how to structure your company for success on both sides of the border.
Your registration is subject to host approval.
OBIO® WiHI Breakfast: Science, Systems and Strategy: Sharing Our Experience Leading A Life Science Start-Up
OBIO® WiHI Breakfast
Join us for our next OBIO® Women in Health Initiative (WiHI) breakfast on March 27 featuring a candid conversation with Defne Garner, Co-Founder & VP, Finance at Ripple Therapeutics and Wendy Naimark, Co-Founder & CTO at Ripple Therapeutics, a clinical stage ophthalmology company. Defne and Wendy will share their career journeys and experiences starting a life science company, raising a $14M USD Series A and an additional $55M USD through partnerships and non-dilutive capital, and securing agreements with three leading strategics. Don’t miss this incredible opportunity to learn first-hand from two women leaders in Canada’s life sciences ecosystem.
We look forward to seeing you there!
*This is an invitation-only event.
Integrating Health Innovation into Canada’s Defence Strategy
In 2026, the convergence of health technology and national security has become a strategic imperative for Canada.
On March 26, OBIO® hosted an insightful discussion in partnership with Invest Ottawa. This event featured industry leaders who addressed how Canada can leverage domestic innovations in dual-use Health Tech and Life Sciences to build a robust, domestic industrial base to strengthen Canada’s sovereignty and security.
Participants learned from expert panelists who develop dual-use health technologies and actively engage with the defence sector.
Agenda
The Foundry at the Bayview Yards, Ottawa
1:00 - 1:30 pm:
Registration
1:30 - 1:45 pm:
Opening remarks by Dr. Maura Campbell (OBIO®)
Fireside Chat 1
1:45 - 2:05 pm:
Opening remarks by Sonya Shorey (Invest Ottawa)
Fireside Chat 2
2:05 - 2:20 pm:
Prensentation by The Royal Ottawa Healthcare Group
2:20 -3:15 pm:
Panel discussion
3:15 -4:30 pm
Networking
Fireside Chats: 1:30 - 2:05 pm
Fireside Chat 1
Dr. Maura Campbell
President and CEO
OBIO®
Aude-Alexia Véronneau
Trade Commissioner (Senior Trade Advisor/Analyst)
Global Affairs Canada
Kasondra White
Acting Director General
Health Emergency Readiness Canada (HERC), Innovation, Science, and Economic Development Canada (ISED)
Fireside Chat 2
Jens Merkel
CFO
Siemens Healthineers Global Center of Excellence for Blood Gas Testing
Sonya Shorey
President and CEO
Invest Ottawa
Presentation from The Royal Ottawa Healthcare Group: 2:05 - 2:20 pm
Transforming Mental Health through Quality, Research, Innovation & Partnership
Florence Dzierszinski
President & CEO, Institute of Mental Health Research
VP Research, The Royal Ottawa Healthcare Group
Cara Vaccarino
President and CEO
The Royal Ottawa Healthcare Group
Panel Discussion: 2:20 - 3:15 pm
Panel discussion on the start-up journey towards dual-use technology for military applications featuring guest speakers Morteza Ahmadi (Qidni Labs), Brian Jahns (Vasomune Therapeutics) and Michael Tessier (Cohesys).
Meet our Panelists
Entrepreneurship Training for Women in STEM: Health & Life Sciences
This event is full! Thank you for your interest.
Entrepreneurship Training for Women in STEM: Health & Life Sciences
OBIO® is pleased to partner with PRiME, the next generation precision medicine initiative at The University of Toronto, and would like to invite women in STEM to apply for its Entrepreneurship Training Program. Delivered in collaboration with PRiME, the program focuses on empowering women innovators advancing innovation in health and life sciences.
About the Program
To address the under representation of women in ownership and leadership positions in life sciences and health tech, OBIO® is launching the Entrepreneurship Training for Women in STEM with a focus on health and life sciences to provide targeted entrepreneurship training for women in STEM.
Through a comprehensive eight-session program (once a week), participants gain entrepreneurial knowledge and access to role models needed to move innovations from lab to market. The curriculum spans the full venture creation lifecycle, covering intellectual property protection and licensing, corporate structure and governance, financing and fundraising, accounting and financial management, project management, and pitching to investors and strategic partners.
What participants can expect:
Gain entrepreneurial knowledge and access to role models needed to move innovations from lab to market
Learn about the full venture creation lifecycle, including intellectual property protection and licensing, corporate structure and governance, financing and fundraising, accounting and financial management, project management, and pitching to investors and strategic partners.
Certificate upon completion of the course.
Who should apply:
We are looking for committed and driven women who are: academic scientist/researchers, graduate students, and post-docs with an interest in entrepreneurship.
Program Details:
Venue:
BioLabs University of Toronto
661 University Ave, Suite 1300
Toronto, ON M5G 1M1
Program Dates (Wednesdays):
March 25 / April 8 / April 22 / May 6
May 20 / June 3 / June 17 / June 24
Time:
5 – 8 pm (in person, Toronto)
Each session will follow a consistent structure, beginning with expert-led content followed by a Q&A and facilitated discussion. The evening will continue with a female founder story, additional discussion, and conclude with networking.
This event is full! Thank you for your interest.
OBIO® Career Fair
OBIO® Career Fair: Pathways to your future in Life Sciences & Health Tech
Join us on March 18 for an interactive event connecting life sciences and health tech talent with industry leaders and organizations. This career-focused event offers opportunities for learning, networking, and professional growth for both job seekers and hiring organizations.
Attendee tickets are now SOLD OUT
Agenda (subject to change)
8:15 - 9:05 am: Registration, Coffee & Networking
9:05 - 9:15 am: Opening Remarks
9:15 - 10 am: Panel 1: Breaking into Biomanufacturing: What Are Employers Looking For
10 - 10:15 am: Q&A
10:15 - 10:45 am: Networking
10:45 - 11:45 am: Interview Workshop
11:45 am - 12 pm: Break
12 - 12:45 pm: Panel 2: Redefining Careers in Life Sciences: How AI is Transforming the Job Market
12: 45 - 1 pm: Q&A
1 - 4 pm: Career Fair
Speakers:
Two Panel Discussions featuring Industry Leaders: Gain insights on career pathways, trends, and what it takes to succeed in the life sciences and health tech sector.
Panel 1 (morning): Breaking into Biomanufacturing: What Are Employers Looking For
Panel 2 (afternoon): Redefining Careers in Life Sciences: How AI is Transforming the Job Market
HR-Led Career Development Workshop: A practical, interactive session focused on interview best practices and how to effectively pitch your skills, experience, and value to employers.
Career Fair: Engage directly with top companies and explore exciting opportunities.
Whether you’re advancing your career or growing your talent pipeline, the OBIO® Career Fair provides the guidance, connections, and opportunities to support your next steps.
REGISTRATION & COST
Participate as an attendee
OBIO® members: FREE (registration required)
Non-members: $20 +HST
This category is sold out!
Thank you for your interest.
Purchase an Exhibitor booth
Includes up to 2 attendees.
Once registered, you will receive an email from the OBIO® Team with additional details.
OBIO® member: FREE (registration required)
Non-members: $350 +HST
Hiring companies: FREE
Please contact Viktoriya Shabat for details.
Thank you to our Sponsors:
ATTENDING EXHIBITORS
*More exhibitors coming soon*
SPONSORSHIP OPPORTUNITIES
Are you interested in becoming an event Sponsor? Do you have any other questions about the OBIO® Career Fair? Please contact Viktoriya Shabat.
CDD x OBIO® Pub Night
Happy Hour
You’re invited to attend a fun night of networking hosted by CDD and OBIO®!
Join us for a relaxing, after-hours gathering bringing together biotech experts and members of the life sciences community. Come catch up with your peers or make some new connections!
When: March 10, 2026 at 5:30 pm
Where: Rooftop on College, 20 College Street, Toronto, Ontario M5G 1K2
What: A fun evening with some drinks & bites
We hope you can make it and look forward to celebrating with you!
Space is limited, so register now.
AI Digital Health Training program
AI Digital Health Training program
OBIO®, in collaboration with Toronto Metropolitan University (TMU), is pleased to announce the launch of the AI Digital Health Training Program. This two-day, in-person training experience designed to equip professionals with the practical skills and strategic insight needed to design, deploy, and scale digital health solutions is part of OBIO’s Cybersecurity & Digital Health Training for Health Science Professionals.
This program focuses on the real-world application of AI and digital technologies across the healthcare and life sciences sectors.
Learning Outcomes:
Navigate adherence requirements for digital health products, including regulatory, cybersecurity, and ethical considerations
Understand industry-adopted AI technologies enabling consumer health application delivery
Analyze existing digital health tools, from product design through to market release
Design scalable digital health solutions that meet stakeholder and patient needs
Integrate user feedback into continuous product improvement cycles
OBIO® Self-Paced Learning (Online)
In addition to the in-person training, participants will receive access to OBIO’s online, self-paced learning materials via OBIO’s learning platform. This supplemental content deepens participants’ understanding of the critical intersection of software development and cybersecurity in digital health and medical devices.
Key topics include:
Regulatory requirements, data compliance, and secure data management across the Software Development Life Cycle (SDLC)
Cybersecurity risks, emerging threats, and their impact on healthcare organizations
Secure software development practices and cloud infrastructure security
Data governance in the era of increasing cyber threats
The role of blockchain in enhancing digital health security
Electronic Health Records (EHR), access controls, and the importance of cybersecurity in healthcare
OBIO® is proud to partner with Upskill Canada (powered by Palette Skills) and the Government of Canada to deliver this training, supporting workforce development and innovation across Canada’s health and life sciences ecosystem.
This program has a value of $2,500 + HST.
The program cost is $150 + HST.
*Spots are limited*
OBIO’s International Women's Day Celebration
OBIO’s International Women's Day Celebration
*This event is sold out! Thank you for your interest.*
OBIO’s International Women’s Day Celebration brings together dynamic women leaders across the health tech and life sciences industry. This event is a unique platform where investors, entrepreneurs and industry professionals gather to celebrate and empower women-driven innovations.
Nine companies from the current cohort of the WiHI Seed program will pitch their groundbreaking solutions, showcasing the incredible potential of women-led start-ups to advance the future of healthcare.
Agenda
-
Registration and Networking
-
Remarks, Panel & Pitches
-
Prizes and Networking
Meet our Speakers
Maura Campbell, PhD
President and CEO, OBIO®
Connie Chen, PhD
Sr. Director, Strategy & Corporate Development, FACIT
Vean Hung, CPA, CA
Partner, Assurance, EY Private and Canada Entrepreneurial Winning Women Program Co-Leader
MP Chi Nguyen
Member of Parliament for Spadina - Harbourfront
Hon. Charmaine A. Williams
Ontario’s Associate Minister of Women's Social and Economic Opportunity
Panel Session:
“From Seed to Scale: Women Leaders on Raising Capital and Scaling Globally in Digital Health & Life Sciences”
Meet our Panelists
Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
Moderator: Maura Campbell, PhD
President and CEO, OBIO®
Marina Cortes
Manager, Business Tax Services, EY
Megan Dover
Junior Partner and Co-founder, Cross-Border Impact Ventures
Mai Elfarnawany
VP of Engineering, Flosonics Medical
Jennifer Humphrey
Associate, Emerging and High Growth Companies, Osler, Hoskin & Harcourt
Meet our Pitching Companies
The event is a great opportunity for attendees to network, collaborate, and invest in the next wave of healthcare innovations, while amplifying the voices of the women shaping the industry.
Sponsored by:
Ticket Prices:
OBIO® Members: $20
Non-Members: $30
*This event is sold out! Thank you for your interest.*
Supported by:
Biomanufacturing for Advanced Therapies Training Program
Registration for this program is currently closed. Please check again later.
If you have any questions or would like information about future training opportunities, please reach out to: training@obio.ca.
The biomanufacturing sector for advanced therapies is experiencing rapid growth and an escalating demand for personnel with specialized skill sets compared to conventional biopharmaceutical manufacturing. To address this need, OBIO® and CATTI have partnered to deliver the Biomanufacturing for Advanced Therapies Training Program, including cell and gene therapy (CGT), funded by Upskill Canada [powered by Palette Skills] and the Government of Canada.
The program focuses on both conceptual and practical skills essential to the development and manufacturing of Advanced Therapy Medicinal Products (ATMPs), with a curriculum developed through extensive collaborations with companies in the sector developing CGTs and tailored to meet their specialized workforce needs.
Upcoming sessions:
March 9-13 | Closed System Manufacturing, CAR-T and Immunotherapies – Guelph
March 16-20 | Aseptic Techniques & Cell Culture – Guelph
OBIO® WiHI Breakfast: Non-Dilutive Funding Opportunities for Health & Life Sciences Start-ups
OBIO® WiHI Breakfast
Join us on February 20 at our next OBIO® Women in Health Initiative (WiHI) breakfast to explore key non-dilutive funding options to fuel your health and life sciences venture - without giving up equity.
We look forward to seeing you there!
*This is an invitation-only event.
Leading with Intelligence: Building an AI-ready Health Organization
Webinar
Leading with Intelligence: Building an AI-ready Health Organization
Join us on February 18 for a webinar on “Leading with Intelligence: Building an AI-ready Health Organization” by OBIO® member Beam Data.
AI’s impact in healthcare is no longer theoretical - it is operational. But real value is realized only when AI is embedded into workflows, aligned with governance structures, and supported by leaders who understand both the technology and the context in which it operates.
Health organizations face unique regulatory, ethical, data, and workforce challenges. Becoming AI-ready requires more than tools - it demands AI literacy at the leadership level, clear governance frameworks, scalable data infrastructure, and a roadmap that connects innovation to measurable patient and business outcomes.
Join distinguished leaders from academia, biotech, pharma, and global health technology including Dr. Wendy Cukier (TMU & Diversity Institute), Daniel Zikovitz (GE Healthcare), Joanna Yu (Takeda Canada), Dr Desmond Pink (Nanostics) and Dr Meraj A Khan (Digibiomics) as they explore practical frameworks for operationalizing AI in Healthcare.
Rifath Mohsen, Healthcare AI and BD Strategist at Beam Data and Bibaswan Ghoshal, Senior Director, Technology Adoption at OBIO®, will moderate this discussion.
This discussion will address:
The latest advances in AI and machine learning shaping healthcare
The governance, regulatory, and workflow realities unique to health organizations
Building AI literacy and human capital for sustainable adoption
Assessing organizational readiness and leadership alignment for AI implementation
AI readiness is not just about technology. It is about leadership, literacy, and execution.
Networking Reception at the OBIO® Investment Summit
*This event is sold out*
As part of the 2026 OBIO® Investment Summit, OBIO® members and ecosystem partners are invited to join us for an evening of networking at the Arcadian Court & Loft in Toronto.
Enjoy drinks & hors oeuvres while catching up with friends, partners and the wider ecosystem, and celebrating the spirit of life sciences innovation.
Make it stand out
Whatever it is, the way you tell your story online can make all the difference.
Registration spots are limited. Please purchase your tickets early
and spread the word with your colleagues.
*NOTE*
If you are already attending the Summit as a presenting company, Early Technology Showcase partner, sponsor or investor, the reception is already included in your registration.
*This event is sold out*
2026 OBIO® Investment Summit
2026 OBIO® Investment Summit
CANADA’S PREMIER HEALTH SCIENCE INVESTMENT EVENT
The OBIO® Investment Summit and Early Technology Showcase is a forum to connect global investors with growing companies, our best technology innovators and ecosystem partners. The Summit also includes the Pharma and MedTech Business Development Forum, which brings together Canada’s life science companies with corporate venture professionals to explore partnerships and licensing opportunities.
Since 2018, the OBIO® Investment Summit has presented high-quality, pre-vetted deal flow to global investors. In addition, the Summit’s Early Technology Showcase featured emerging companies coming out of Canada’s preeminent health research institutions.
To learn more about the OBIO® Investment Summit, visit: www.obioinvestmentsummit.com.